<?xml version="1.0" encoding="UTF-8"?>
<p>The NLRP3 inflammasome has been implicated in the development of CHIKV-induced inflammation in the footpad of injected mice [
 <xref rid="ppat.1007934.ref017" ref-type="bibr">17</xref>]. We injected MAYV at 10
 <sup>5</sup> or 10
 <sup>6</sup> PFU dose in the footpad of WT and 
 <italic>Nlrp3</italic>
 <sup>
  <italic>-/-</italic>
 </sup> mice and observed that 
 <italic>Nlrp3</italic>
 <sup>
  <italic>–/–</italic>
 </sup>mice had increased footpad swelling compared to WT mice at 5 days post infection with a dose of 10
 <sup>5</sup> PFU and at 6 days post infection with a dose of 10
 <sup>6</sup> PFU (
 <xref ref-type="fig" rid="ppat.1007934.g005">Fig 5A, 5B and 5C</xref>). Representative images of infected WT and 
 <italic>Nlrp3</italic>
 <sup>
  <italic>–/–</italic>
 </sup>mice are shown for both mock and MAYV-infected animals (
 <xref ref-type="fig" rid="ppat.1007934.g005">Fig 5D</xref>). We next infected two independently generated 
 <italic>Nlrp3</italic>
 <sup>
  <italic>–/–</italic>
 </sup>mice [
 <xref rid="ppat.1007934.ref040" ref-type="bibr">40</xref>,
 <xref rid="ppat.1007934.ref041" ref-type="bibr">41</xref>] and 
 <italic>Casp1/11</italic>
 <sup>
  <italic>-/-</italic>
 </sup> mice with 10
 <sup>5</sup> PFU dose of MAYV and we observed that footpad swelling was significantly higher in these deficient strains compared to WT mice (
 <xref ref-type="fig" rid="ppat.1007934.g005">Fig 5E</xref>). Of note, 
 <italic>Nlrp3</italic>
 <sup>
  <italic>–/–</italic>
 </sup>mice showed reduced pain hypersensitivity at earlier time points upon infection but developed pain hypersensitivity similar to WT mice after 5 days of infection (
 <xref ref-type="fig" rid="ppat.1007934.g005">Fig 5F and 5G</xref>).
</p>
